Update on depression in neurologic illness: Stroke, epilepsy, and multiple sclerosis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current Psychiatry Reports

• Publication date

  2005-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/S11920-005-0043-2PMID 16216161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Depression in Multiple Sclerosis: Review and Meta‐analysis

  2006cited by this paper
• A preliminary report on a skills-based telephone-administered peer support programme for patients with multiple sclerosis

  2005cited by this paper
• Depression and Anxiety Disorders in Pediatric Epilepsy

  2005cited by this paper
• Depression and Mania in Patients with Epilepsy

  2005cited by this paper
• Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke

  2005cited by this paper
• Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice.

  2005cited by this paper
• The association of depression with disease course in multiple sclerosis

  2005cited by this paper
• The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis

  2005cited by this paper
• Mood disorders and their treatment in patients with epilepsy.

  2005cited by this paper
• Primidone is associated with interictal depression in patients with epilepsy.

  2005cited by this paper
• Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy.

  2005cited by this paper
• Cognitive impairment associated with major depression following mild and moderate traumatic brain injury.

  2005cited by this paper
• Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation.

  2005cited by this paper
• Gender differences in risk factors of suicidal behavior in epilepsy.

  2005cited by this paper
• Depression and fatigue in relapsing-remitting MS: the role of symptomatic variability

  2005cited by this paper
• Antiepileptic Drugs and the Regulation of Mood and Quality of Life (QOL): The Evidence from Epilepsy

  2005cited by this paper
• Poststroke Depression in Chinese Patients: Frequency, Psychosocial, Clinical, and Radiological Determinants

  2005cited by this paper
• Self-Reported Depression and Use of Antidepressants After Stroke: A National Survey

  2004cited by this paper
• The Neuropsychiatry of Multiple Sclerosis

  2004cited by this paper
• Interventions for treating depression after stroke.

  2004cited by this paper
• Genes, environment, and susceptibility to multiple sclerosis.

  2004cited by this paper
• Screening post-stroke depression in Chinese older adults using the hospital anxiety and depression scale

  2004cited by this paper
• Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke.

  2004influential reference
• Depression and anxiety before and after temporal lobe epilepsy surgery.

  2004cited by this paper
• Structural brain abnormalities in multiple sclerosis patients with major depression

  2004cited by this paper
• Vascular disease/risk and late-life depression in a Korean community population

  2004cited by this paper
• Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study

  2004cited by this paper
• Fluvoxamine treatment of major depression associated with multiple sclerosis.

  2004cited by this paper
• Depression and other mental health diagnoses increase mortality risk after ischemic stroke.

  2004cited by this paper
• Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5‐HT1A receptors

  2004cited by this paper
• Is poststroke depression a vascular depression?

  2004cited by this paper
• Post-stroke and clinically-defined vascular depression in geriatric rehabilitation patients.

  2004cited by this paper
• Citalopram as Treatment of Depression in Patients With Epilepsy

  2004cited by this paper
• Mood Disturbance before and after Seizure Surgery: A Comparison of Temporal and Extratemporal Resections

  2004cited by this paper
• Peer support groups in multiple sclerosis: current effectiveness and future directions

  2004cited by this paper
• Prediction of the response to citalopram and reboxetine in post-stroke depressed patients

  2004cited by this paper
• Perception of prognostic risk in patients with multiple sclerosis: the relationship with anxiety, depression, and disease-related distress.

  2004cited by this paper
• Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy

  2004cited by this paper
• Depression and comorbidity in community-based patients with epilepsy or asthma

  2004cited by this paper
• Depressed mood and memory impairment in temporal lobe epilepsy as a function of focus lateralization and localization.

  2004cited by this paper
• Prevalence of post-stroke depression in an Irish sample and its relationship with disability and outcome following inpatient rehabilitation

  2004cited by this paper
• Life Review Therapy as an Intervention to Manage Depression and Enhance Life Satisfaction in Individuals with Right Hemisphere Cerebral Vascular Accidents

  2004cited by this paper
• Poststroke depression and lesion location revisited.

  2004cited by this paper
• Cerebrovascular Reactivity in Major Depression: A Pilot Study

  2004cited by this paper
• Epilepsy and depression: risk factors for suicide?

  2004cited by this paper
• The relation between brain MRI lesions and depressive symptoms in multiple sclerosis.

  2003cited by this paper
• Cognitive Behavioral Psychotherapy for Depression Following Stroke: A Randomized Controlled Trial

  2003cited by this paper
• Major depression in multiple sclerosis

  2003cited by this paper
• Ischemic stroke and depression.

  2003influential reference
• Does Serotonin Play a Role in Epilepsy?

  2003cited by this paper
• Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.

  2003cited by this paper
• Symptoms of depression in older adults with multiple sclerosis (MS): Comparison with a matched sample of younger adults

  2003cited by this paper
• Effects of psychological group therapy in patients with multiple sclerosis

  2003cited by this paper
• Depression in Intractable Partial Epilepsy Varies by Laterality of Focus and Surgery

  2003cited by this paper
• POST-STROKE DEPRESSION : A DOUBLE-BLIND STUDY

  2003cited by this paper
• A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis.

  2003cited by this paper
• Poststroke depression: prevalence, diagnosis, treatment, and disease progression.

  2003cited by this paper
• The role of illness severity and illness representations in adjusting to multiple sclerosis.

  2003cited by this paper
• Early fluoxetine treatment of post-stroke depression

  2003cited by this paper
• Mortality and poststroke depression: a placebo-controlled trial of antidepressants.

  2003cited by this paper
• Depression in epilepsy: a frequently neglected multifaceted disorder.

  2003cited by this paper
• Effects of Treatment for Depression on Fatigue in Multiple Sclerosis

  2003cited by this paper
• Common pathogenic mechanisms between depression and epilepsy: an experimental perspective.

  2003cited by this paper
• Detecting Depression in Chinese Stroke Patients: A Pilot Study Comparing Four Screening Instruments

  2003cited by this paper
• Depressive symptoms in a treated multiple sclerosis cohort

  2003cited by this paper
• Multiple Sclerosis, interferon beta-1b and depression

  2002cited by this paper
• Depressive symptoms and MRI changes in multiple sclerosis

  2002cited by this paper
• Emotional and affective disturbances in patients with epilepsy.

  2002cited by this paper
• Randomized Double‐blind Parallel‐group Study Comparing Cognitive Effects of a Low‐dose Lamotrigine with Valproate and Placebo in Healthy Volunteers

  2002cited by this paper
• Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis.

  2002cited by this paper
• Effects of Fluoxetine and TFMPP on Spontaneous Seizures in Rats with Pilocarpine‐induced Epilepsy

  2002cited by this paper
• Expression of tumor necrosis factor-α and interferon-γ mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis

  2002cited by this paper
• Depression and epilepsy: How closely related are they?

  2002cited by this paper
• Interferon &bgr;1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial

  2002cited by this paper
• Multiple sclerosis, interferon beta-1b and depression A prospective investigation.

  2002cited by this paper
• Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis.

  2001cited by this paper
• Depression & stroke. Improving patient outcomes with a team approach.

  2001cited by this paper
• Depression and Anxiety in Patients with Epilepsy

  2001cited by this paper
• Impact of depressed mood on neuropsychological status in temporal lobe epilepsy

  2001cited by this paper
• A Case-Control Study

  2001cited by this paper
• Authors should be accurate when describing study design.

  2001cited by this paper
• Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis.

  2001cited by this paper
• Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

  2001cited by this paper
• Depression and Anxiety in Patients with Epilepsy.

  2001cited by this paper
• Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects

  2001cited by this paper
• Interferon β-1a and depression in relapsing - remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial

  2001cited by this paper
• Feasibility and Effectiveness of Treatments for Post-Stroke Depression in Elderly Inpatients: Systematic Review

  2001cited by this paper
• Major depression is a risk factor for seizures in older adults

  2000cited by this paper
• Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial.

  2000cited by this paper
• Depression after stroke and lesion location: a systematic review.

  2000cited by this paper
• Multiple sclerosis, disease modifying treatments and depression: a critical methodological review

  2000cited by this paper
• Moderators of the Effect of Preoperative Emotional Adjustment on Postoperative Depression After Surgery for Temporal Lobe Epilepsy

  2000cited by this paper
• Lesion pattern in patients with multiple sclerosis and depression

  2000cited by this paper
• Psychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectomy

  2000cited by this paper
• Fluoxetine in early poststroke depression: a double-blind placebo-controlled study.

  2000cited by this paper
• Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

  2000cited by this paper
• Susceptibility to multiple sclerosis: interplay between genes and environment.

  2000cited by this paper
• Beck Depression Inventory factors related to demyelinating lesions of the left arcuate fasciculus region.

  2000cited by this paper
• Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis.

  2000cited by this paper
• Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis.

  2000cited by this paper

• Evolution of paradigms in the study of depression: from a unitary concept to a biopsychosocial model and interdisciplinary approaches

  2022cites this paper
• Evolution of paradigms in the study of depression: from a unitary concept to a biopsychosocial model and interdisciplinary approaches Kornetov

  2022cites this paper
• Stroke in Young Adults

  2020cites this paper
• Depression and Inflammatory Periodontal Disease Considerations—An Interdisciplinary Approach

  2016cites this paper
• Depression and Multiple Sclerosis

  2012cites this paper
• Chapitre 15 – Troubles somatoformes et intrications médicopsychiatriques

  2012cites this paper
• Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.

  2011cites this paper
• Common Pathways to Neurodegeneration and Co-morbid Depression

  2010cites this paper
• Therapeutic effects of drug therapy with and without cognitive behaviour therapy in post-stroke depression

  2010cites this paper
• Brain Protection in Schizophrenia, Mood and Cognitive Disorders

  2010cites this paper
• Differential diagnosis of depressive illness versus intense normal sadness: how significant is the ‘clinical significance criterion’ for major depression?

  2010cites this paper
• Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.

  2008cites this paper
• Stroke in Young Adults

  2008cites this paper
• ntroduction: Chronic Medical Conditions and epression—the View from Primary Care

  2008cites this paper
• Multiple sclerosis and behavior.

  2007cites this paper